Market Risers: Oncimmune Holdings, Safestyle UK, Smith & Nephew

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Stock in Oncimmune Holdings found using EPIC: LON:ONC has risen 5.93% or 7.5 points during the course of today’s session so far. Investors are a positive bunch throughout the trading session. The periods high figure was 134.4 meanwhile the session low reached 131.95. The total volume of shares exchanged so far has reached 6,947 while the daily average number of shares exchanged is 394,693. The 52 week high for the share price is 139.95 which comes in at 13.45 points difference from the previous days close and putting the 52 week low at 30 is a variance of 96.5 points. Oncimmune Holdings has a 20 day moving average of 132.8 and now its 50 day moving average at 109.2. The current market cap is £85.09m at the time of this report. The currency for this stock is Great British pence.Market cap is measured in GBP. This article was written with the last trade for Oncimmune Holdings being recorded at Wednesday, July 1, 2020 at 11:29:35 AM GMT with the stock price trading at 134 GBX.

The share price for Safestyle UK EPIC code: LON:SFE has moved up 4.17% or 1.1 points throughout the session so far. Buyers have stayed positive throughout the session. The period high was 27.5 while the low for the session was 27.15. The total volume of shares exchanged through this period comes to 2,459 while the daily average number of shares exchanged is 154,854. The 52 week high for the share price is 78 around 51.6 points difference from the previous days close and the 52 week low at 14 a difference of some 12.4 points. Safestyle UK now has a 20 SMA at 28.82 with a 50 day simple moving average now of 27.51. The market capitalisation currently stands at £36.52m at the time of this report. The stock is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Safestyle UK being recorded at Wednesday, July 1, 2020 at 10:33:39 AM GMT with the stock price trading at 27.5 GBX.

The stock price for Smith & Nephew EPIC code: LON:SN has stepped up 3.89% or 58.5 points during today’s session so far. Buyers have stayed positive while the stock has been in play. The periods high figure was 1593 and a low of 1522.5. The number of shares traded by this point in time totalled 2,917,418 while the daily average number of shares exchanged is 2,238,059. A 52 week share price high is 2023 which comes in at 517.5 points in difference to the previous days close of business and a 52 week low sitting at 1055.01 is a variance of 450.49 points. Smith & Nephew now has a 20 SMA at 1638.76 and now a 50 day SMA of 1632.44. This puts the market capitalisation now at £13,571.26m at the time of this report. The share price is in GBX. Mcap is measured in GBP. This article was written with the last trade for Smith & Nephew being recorded at Wednesday, July 1, 2020 at 12:28:55 PM GMT with the stock price trading at 1564 GBX.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    Smith & Nephew's Q3 2024 update shows a 4% revenue growth to $1,412M. Despite China headwinds, US Orthopaedics and Sports Medicine excelled.
    Smith & Nephew plc (LON:SN, NYSE:SNN) reports a robust financial performance for Q2 and H1 2024, showing significant revenue and profit growth.
    Smith+Nephew plc (LON:SN, NYSE:SNN) reports Q1 revenue of $1,386 million, up 2.9% underlying. Orthopaedics and Sports Medicine show strong growth. CEO confident in outlook.
    Smith+Nephew plc reports solid financial results for Q4 and full year 2023, showcasing growth in revenue and profit margins. Analyst call scheduled for 27 Feb 2024.
    Safestore Holdings plc appoints Simon Clinton as Chief Financial Officer, bringing extensive experience in real estate, retail, and consumer sectors.
    Smith+Nephew plc (LON:SN, NYSE:SNN) will be attending AAOS 2024 Annual Meeting to showcase its innovative medical technology solutions in San Francisco. Learn about their latest products and updates in the orthopaedic field.

      Search

      Search